Skip to content

ARRAY BIOPHARMA INC

Delisted

CIK 1100412fmd_19552NAZGC6RXBTFCN1FPYVHYVManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jul 01, 2009 to Mar 31, 2019, 36 periods

Latest annual · FY2018

Millions
Total revenues
174
Gross profit
114
Operating income
(130)
Net income
(147)
Free cash flow
(121)

Latest quarter · Q3 FY2019

Millions
Total revenues
65
Gross profit
64
Operating income
(37)
Net income
(37)
Free cash flow
(45)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2015 to FY2018
+49.6%
Revenue, 5 yearsFY2013 to FY2018
+20.1%
Net income, 5 yearsFY2013 to FY2018
n/m

ARRAY BIOPHARMA INC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2018FY2017ChangeSource
Revenue$173.8 million$150.9 million+15.2%10-K 2018-08-14 · proof
Gross profit$114.4 million$115.5 million-0.9%10-K 2018-08-14 · proof
Operating income-$129.9 million-$102.1 million10-K 2018-08-14 · proof
Net income-$147.3 million-$116.8 million10-K 2018-08-14 · proof
Cash from operating activities-$119.8 million-$39.4 million10-K 2018-08-14 · proof
Free cash flow-$121 million-$42.9 million10-K 2018-08-14 · proof
Total assets$460.4 million$279.1 million+64.9%10-K 2018-08-14 · proof
Total liabilities$240.6 million$267.4 million-10%10-K 2018-08-14 · proof
Cash and cash equivalents$114.7 million$125.9 million-8.9%10-K 2018-08-14 · proof
Total debt$111.8 million$95.9 million+16.6%10-K 2018-08-14 · proof
What was ARRAY BIOPHARMA INC's revenue in fiscal 2018?
ARRAY BIOPHARMA INC reported revenue of $173.8 million for fiscal 2018 (the year ended Jun 30, 2018), against $150.9 million the year before (+15.2%). Source: the 10-K filed with the SEC on Aug 14, 2018. SEC
What was ARRAY BIOPHARMA INC's gross profit in fiscal 2018?
ARRAY BIOPHARMA INC reported gross profit of $114.4 million for fiscal 2018 (the year ended Jun 30, 2018), against $115.5 million the year before (-0.9%). Source: the 10-K filed with the SEC on Aug 14, 2018. SEC
What was ARRAY BIOPHARMA INC's operating income in fiscal 2018?
ARRAY BIOPHARMA INC reported operating income of -$129.9 million for fiscal 2018 (the year ended Jun 30, 2018), against -$102.1 million the year before. Source: the 10-K filed with the SEC on Aug 14, 2018. SEC
What was ARRAY BIOPHARMA INC's net income in fiscal 2018?
ARRAY BIOPHARMA INC reported net income of -$147.3 million for fiscal 2018 (the year ended Jun 30, 2018), against -$116.8 million the year before. Source: the 10-K filed with the SEC on Aug 14, 2018. SEC
What was ARRAY BIOPHARMA INC's cash from operating activities in fiscal 2018?
ARRAY BIOPHARMA INC reported cash from operating activities of -$119.8 million for fiscal 2018 (the year ended Jun 30, 2018), against -$39.4 million the year before. Source: the 10-K filed with the SEC on Aug 14, 2018. SEC
What was ARRAY BIOPHARMA INC's free cash flow in fiscal 2018?
ARRAY BIOPHARMA INC reported free cash flow of -$121 million for fiscal 2018 (the year ended Jun 30, 2018), against -$42.9 million the year before. Source: the 10-K filed with the SEC on Aug 14, 2018. SEC
What are ARRAY BIOPHARMA INC's total assets?
As of Jun 30, 2018, ARRAY BIOPHARMA INC reported total assets of $460.4 million, against $279.1 million a year earlier (+64.9%). Source: the 10-K filed with the SEC on Aug 14, 2018. SEC
What are ARRAY BIOPHARMA INC's total liabilities?
As of Jun 30, 2018, ARRAY BIOPHARMA INC reported total liabilities of $240.6 million, against $267.4 million a year earlier (-10%). Source: the 10-K filed with the SEC on Aug 14, 2018. SEC
What are ARRAY BIOPHARMA INC's cash and cash equivalents?
As of Jun 30, 2018, ARRAY BIOPHARMA INC reported cash and cash equivalents of $114.7 million, against $125.9 million a year earlier (-8.9%). Source: the 10-K filed with the SEC on Aug 14, 2018. SEC
What is ARRAY BIOPHARMA INC's total debt?
As of Jun 30, 2018, ARRAY BIOPHARMA INC reported total debt of $111.8 million, against $95.9 million a year earlier (+16.6%). Source: the 10-K filed with the SEC on Aug 14, 2018. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1100412&period_type=annual&limit=5"

Information only, not investment advice.